Clinical illness and outcomes in patients with Ebola in Sierra Leone

New England Journal of Medicine

Volumn 371, Issue 22, 2014, Pages 2092-2100

  Schieffelin, John S ^a   Shaffer, Jeffrey G ^b   Goba, Augustine ^c   Gbakie, Michael ^c   Gire, Stephen K ^g,h   Colubri, Andres ^g   Sealfon, Rachel S G ^h,i   Kanneh, Lansana ^c   Moigboi, Alex ^c   Momoh, Mambu ^c,d   Fullah, Mohammed ^c,d   Moses, Lina M ^a   Brown, Bethany L ^j   Andersen, Kristian G ^g,h   Winnicki, Sarah ^g,h   Schaffner, Stephen F ^g,h   Park, Daniel J ^h   Yozwiak, Nathan L ^g,h   Jiang, Pan Pan ^g,h   Kargbo, David ^c   Jalloh, Simbirie ^c   Fonnie, Mbalu ^c   Sinnah, Vandi ^c   French, Issa ^c   Kovoma, Alice ^c   Kamara, Fatima K ^c   Tucker, Veronica ^c   Konuwa, Edwin ^c   Sellu, Josephine ^c   Mustapha, Ibrahim ^c   Foday, Momoh ^c   Yillah, Mohamed ^c   Kanneh, Franklyn ^c   Saffa, Sidiki ^c   Massally, James L B ^c   Boisen, Matt L ^j   Branco, Luis M ^k   Vandi, Mohamed A ^e   Grant, Donald S ^c   Happi, Christian ^l   Gevao, Sahr M ^f   Fletcher, Thomas E ^m   Fowler, Robert A ⁿ   Bausch, Daniel G ^b,o   Sabeti, Pardis C ^g,h   Khan, S Humarr ^c   Garry, Robert F ^a   KGH Lassa Fever Program, ^p   more..

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c Kenema Government Hospital   (Sierra Leone)

^d Eastern Technical University   (Sierra Leone)

^e MINISTRY OF HEALTH AND SANITATION   (Sierra Leone)

^f UNIVERSITY OF SIERRA LEONE   (Sierra Leone)

^g HARVARD UNIVERSITY   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j Corgenix Medical ^*  (United States)

^k Zalgen Labs   (United States)

^l REDEEMER S UNIVERSITY   (Nigeria)

^m LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

ⁿ UNIVERSITY OF TORONTO   (Canada)

^o California   (Peru)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMPICILLIN; ANTIMALARIAL AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CARBON DIOXIDE; CEFTRIAXONE; CHLORIDE; CIPROFLOXACIN; CREATININE; GLUCOSE; METRONIDAZOLE; POTASSIUM; UREA;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; ARTICLE; BLEEDING; BODY TEMPERATURE; CLINICAL FEATURE; CONFUSION; CONJUNCTIVITIS; CONVULSION; CORRELATIONAL STUDY; COUGHING; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; EBOLA VIRUS; EBOLA VIRUS DISEASE; EDEMA; FATALITY; FEMALE; FEVER; FILOVIRUS INFECTION; FLUID THERAPY; HEADACHE; HEARING IMPAIRMENT; HUMAN; INCUBATION TIME; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIERRA LEONE; SORE THROAT; SURVIVAL; TREATMENT OUTCOME; VIRUS LOAD; VOMITING; ANIMAL; COMPLICATION; EPIDEMIC; EPIDEMIOLOGY; GENETICS; HEMORRHAGIC FEVER, EBOLA; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; VIROLOGY;

ABDOMINAL PAIN; ADULT; ANIMALS; DIARRHEA; EBOLAVIRUS; EPIDEMICS; FEMALE; FEVER; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; MIDDLE AGED; MORTALITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIERRA LEONE; VIRAL LOAD; VOMITING;

EID: 84912539213     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1411680     Document Type: Article

References (24)

1. World Health Organization. Ebola response roadmap situation report. October 25, 2014 (http://www.who.int/csr/disease/ebola/situation-reports/en).
2. McCarthy M. Ebola is diagnosed in traveler to US. BMJ 2014;349:g5980.
3. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014;371:1418-25.
4. Bausch DG, Schwarz L. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 2014;8(7):e3056.
5. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014;345:1369-72.
6. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011;204:Suppl 3:S810-S816.
7. Fowler RA, Fletcher T, Fischer WA II, et al. Caring for critically ill patients with Ebola virus disease: perspectives from West Africa. Am J Respir Crit Care Med 2014;190:733-7.
8. Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror 2011;9:361-71.
9. Ndambi R, Akamituna P, Bonnet MJ, Tukadila AM, Muyembe-Tamfum JJ, Colebunders R. Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179:Suppl 1: S8-S10.
10. Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999;235:97-116.
11. Khan SH, Goba A, Chu M, et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 2008;78:103-15.
12. Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis 2014;8(3):e2748.
13. World Health Organization, Centers for Disease Control and Prevention. Case definition recommendations for Ebola or Marburg virus diseases. In: Kasolo F, Roungou JB, Perry H, eds. Technical guidelines for integrated disease surveillance and response in the African region. 2nd ed. October 2010:270-4 (http://www.afro.who.int/en/clusters-a-programmes/dpc/integrated-disease-surveillance/features/2775-technical-guidelines-for-integrated-disease-surveillance-and-response-in-the-african-region.html).
14. WHO Ebola Response Team. Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. N Engl J Med 2014;371:1481-95.
15. Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clin Microbiol Infect 2000;6:633-4.
16. Adesunkanmi ARK, Oseni SA, Adejuyigbe O, Agbakwuru EA. Acute generalized peritonitis in African children: assessment of severity of illness using modified APACHE II score. ANZ J Surg 2003;73:275-9.
17. Adesunkanmi ARK, Badmus TA, Fadiora FO, Agbakwuru EA. Generalized peritonitis secondary to typhoid ileal perforation: assessment of severity using modified APACHE II score. Indian J Surg 2005;67:29-33.
18. Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis 1999;179:Suppl 1:S24-S27.
19. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouseadapted variant of Ebola Zaire virus. J Comp Pathol 2001;125:243-53.
20. Fisher-Hoch SP, Platt GS, Lloyd G, Simpson DI, Neild GH, Barrett AJ. Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 1983;2:1055-8.
21. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003;188:1618-29.
22. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978;56:271-93.
23. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and Ddimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007;196:Suppl 2:S364-S371.
24. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:Suppl 2: S142-S147.